Preclinical characterization and phase 1 clinical testing of targeting mitochondrial peroxiredoxin 3 in cancer

V Victoria Gibson J Joanna Dzialo T Terri Messier A Aleksandra Bzura C Charlotte Poile J Jan Rogel J Jens C. Hahne A Aida Habibovic S Stephanie Stead A Alexis Saaman K Kevin G. Blyth P Peter W. Szlosarek S Simon Lord F Fiona Thistlethwaite M Min Zhang A Apostolos Nakas P Peter Wells-Jordan K Kudzayi Kutywayo K Kelly J. Butnor N Nicholas. H. Heintz G George N. Naumov M Maurice Dungey J Julio Herrero Colomina B Burak Aktas S Sean Dulloo J James Spicer D Dean A. Fennell B Brian Cunniff

Article Details

Volume / Issue Vol. 17, Issue 1
Published July 14, 2026
ISSN 2041-1723
Publisher Nature Portfolio

Journal Info

Nature Communications

Nature Portfolio

ISSN: 2041-1723 Open Access Life Sciences

Authors (28)

V

Victoria Gibson

J

Joanna Dzialo

T

Terri Messier

A

Aleksandra Bzura

C

Charlotte Poile

J

Jan Rogel

J

Jens C. Hahne

A

Aida Habibovic

S

Stephanie Stead

A

Alexis Saaman

K

Kevin G. Blyth

P

Peter W. Szlosarek

S

Simon Lord

F

Fiona Thistlethwaite

M

Min Zhang

A

Apostolos Nakas

P

Peter Wells-Jordan

K

Kudzayi Kutywayo

K

Kelly J. Butnor

N

Nicholas. H. Heintz

G

George N. Naumov

M

Maurice Dungey

J

Julio Herrero Colomina

B

Burak Aktas

S

Sean Dulloo

J

James Spicer

D

Dean A. Fennell

B

Brian Cunniff